Evidence map›Paper›PMID 39113958›Full record

ArticleHeliyon2024

Effect of trialkoxysilane/aminosilane-containing universal adhesive on resin-ceramic microtensile bond strength and ceramic wettability: An in-vitro study.

Ali Robaian

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ali RobaianDepartment of Conservative Dental Sciences, The College of Dentistry, Prince Sattam Bin Abdulaziz University, Al-Kharj, 11942, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The dual-silane (trialkoxysilane/aminosilane) universal adhesive (UA) is claimed for its enhanced priming capacity of glass-ceramics. Objective: This study evaluated the effect of organofunctional trialkoxysilane- and organofunctional trialkoxysilane/aminosilane-containing UAs on the long-term resin-ceramic microtensile bond strength (μTBS) and wettability of ceramic. Methods: Hydrofluoric acid-etched lithium disilicate discs were distributed into four groups as follows: (control), no priming was performed; (MBN), primed using a silane-based primer (Monobond N); (SBU), primed using a trialkoxysilane-containing UA (Single Bond Universal Adhesive) and (SBP), primed using a trialkoxysilane/aminosilane-containing UA (Scotchbond Universal Plus Adhesive). Ceramic discs were cemented into blocks then sectioned into microbeams stored in distilled water at 37° for 1 year. The μTBS was evaluated followed by assessment of the failure modes. The contact angle of the two UAs was measured with a goniometer using the sessile drop technique. Results: MBN significantly improved the resin-ceramic μTBS (31.71 ± 6.33 MPa) compared to the control group. The resin-ceramic μTBS obtained after priming using SBP (22.83 ± 3.42 MPa) was comparable to those of MBN. SBU showed significantly inferior resin-ceramic μTBS (16.02 ± 6.28 MPa) compared with MBN. Mixed failures mode patterns were the most frequent in the groups. The ceramic wettability of both UAs did not significantly differ. Conclusion: Ceramic priming using a UA with dual-silane monomers (organofunctional trialkoxysilane/aminosilane) resulted in long-term adhesion comparable to a silane-containing primer. Incorporating aminosilane monomer in UA formulation did not affect the wetting of characteristics of the UA solution and enhanced its glass-ceramic priming capacity. Clinical significance: The use of UA with optimized silane content as a primer for glass-ceramics simplifies clinical adhesive procedures including resin cementation and repair of ceramic restorations.

Indexed as

AdhesivesCeramicsDental cements

Identifiers

PMID39113958
PMCPMC11305263

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.